1. Home
  2. SIEB vs TTRX Comparison

SIEB vs TTRX Comparison

Compare SIEB & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Siebert Financial Corp.

SIEB

Siebert Financial Corp.

HOLD

Current Price

$3.02

Market Cap

164.1M

Sector

Finance

ML Signal

HOLD

TTRX

Turn Therapeutics Inc.

N/A

Current Price

$4.73

Market Cap

138.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SIEB
TTRX
Founded
1886
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
164.1M
138.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SIEB
TTRX
Price
$3.02
$4.73
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$8.00
AVG Volume (30 Days)
15.3K
64.6K
Earning Date
11-12-2025
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.18
N/A
Revenue
$90,289,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$17.05
N/A
Revenue Growth
8.32
N/A
52 Week Low
$2.08
$2.57
52 Week High
$5.77
$26.50

Technical Indicators

Market Signals
Indicator
SIEB
TTRX
Relative Strength Index (RSI) 37.04 N/A
Support Level $2.92 N/A
Resistance Level $3.24 N/A
Average True Range (ATR) 0.17 0.00
MACD -0.07 0.00
Stochastic Oscillator 8.70 0.00

Price Performance

Historical Comparison
SIEB
TTRX

About SIEB Siebert Financial Corp.

Siebert Financial Corp is a diversified financial services firm and provides a full range of brokerage and financial advisory services including securities brokerage, investment advisory and insurance offerings, and corporate stock plan administration solutions. The firm mainly provides online and traditional brokerage and related services to retail investors and also acts as an investment advisor for its subsidiary. The company operates in the securities brokerage and asset management industry. It also engages in Insurance services, Robo-advisory technology, and Prime brokerage business through its subsidiaries.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology company focused on developing pharmaceutical and medical device products for dermatology, wound care, and infectious disease. The company's proprietary platform technology, called PermaFusion, enhances drug performance by improving the stability and bioavailability of active pharmaceutical ingredients, which allows for reduced doses and fewer side effects. Its primary development programs target skin conditions such as moderate to severe eczema and onychomycosis.

Share on Social Networks: